| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1161/CIRCINTERVENTIONS.113.001009 |
| P698 | PubMed publication ID | 24668227 |
| P50 | author | Eric Boersma | Q57288054 |
| P2093 | author name string | Henricus J Duckers | |
| Jaco H Houtgraaf | |||
| Sanaz Samiei | |||
| Renate de Jong | |||
| P433 | issue | 2 | |
| P921 | main subject | myocardial infarction | Q12152 |
| meta-analysis | Q815382 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 156-167 | |
| P577 | publication date | 2014-03-25 | |
| P1433 | published in | Circulation: Cardiovascular Interventions | Q60855009 |
| P1476 | title | Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | |
| P478 | volume | 7 |
| Q38308664 | A journey from basic stem cell discovery to clinical application: the case of adventitial progenitor cells |
| Q28082162 | Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials |
| Q89484527 | An Introduction to Computational Modeling of Cardiac Electrophysiology and Arrhythmogenicity |
| Q38235169 | An update on stem cell therapies for acute coronary syndrome |
| Q36108754 | Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy |
| Q92292792 | Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology |
| Q55348173 | Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials. |
| Q44254145 | Bone marrow cell therapies in ischemic cardiomyopathy |
| Q39017865 | Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells |
| Q47763392 | Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair |
| Q35156767 | Cardiac function in a long-term follow-up study of moderate and severe porcine model of chronic myocardial infarction |
| Q42564441 | Cell therapy for patients with acute myocardial infarction: ACCRUEd evidence to date |
| Q27026350 | Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells |
| Q35952100 | Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury |
| Q46525822 | Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction |
| Q38583455 | Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand? |
| Q42392798 | Consistently Inconsistent-Bone Marrow Mononuclear Stem Cell Therapy Following Acute Myocardial Infarction: A Decade Later |
| Q38697092 | Current State of Stem Cell Therapy for Ischemic Heart Disease |
| Q38658740 | Direct cellular reprogramming for cardiac repair and regeneration |
| Q36169861 | Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis |
| Q92513382 | Effect of Stem Cell Therapy on Patients' Quality of Life in Heart Failure with Reduced Ejection Fraction |
| Q47890976 | Emerging Therapies for Congestive Heart Failure |
| Q30367803 | Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells |
| Q50434191 | Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity. |
| Q28073078 | Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery |
| Q29994502 | Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction |
| Q49171170 | Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials |
| Q55040403 | Impact of bone marrow mononuclear cells therapy on left ventricular function in patients with ST-elevated myocardial infarction: A meta-analysis. |
| Q36169198 | Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study |
| Q52730314 | Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis. |
| Q64075687 | Mesenchymal Stromal Cell Derived Extracellular Vesicles Reduce Hypoxia-Ischaemia Induced Perinatal Brain Injury |
| Q42348036 | Mesenchymal stromal cells and ischemic heart disease: hitting the target? |
| Q36807360 | Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies |
| Q30896351 | Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data |
| Q30819543 | Microcirculatory Response In Vivo on Local Intraarterial Infusion of Autogenic Adipose-derived Stem Cells or Stromal Vascular Fraction |
| Q35959084 | Molecular imaging of stem cells for the treatment of acute myocardial infarction |
| Q33612426 | Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment. |
| Q48155889 | Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed |
| Q90267302 | Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells |
| Q38801590 | Novel cardioprotective and regenerative therapies in acute myocardial infarction: a review of recent and ongoing clinical trials |
| Q47200001 | Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling. |
| Q64055065 | Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure |
| Q49288386 | Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. |
| Q36262927 | Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials |
| Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
| Q92359410 | Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy |
| Q38466418 | Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials |
| Q40967349 | Skeletal muscle-derived interstitial progenitor cells (PICs) display stem cell properties, being clonogenic, self-renewing, and multi-potent in vitro and in vivo |
| Q48083777 | Stem Cell Therapy and Congenital Heart Disease |
| Q47719713 | Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects |
| Q30239945 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. |
| Q24186920 | Stem cell treatment for acute myocardial infarction |
| Q38268628 | Stem cells can form gap junctions with cardiac myocytes and exert pro-arrhythmic effects. |
| Q52724750 | Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial. |
| Q58595974 | Stem/Progenitor Cells and Their Therapeutic Application in Cardiovascular Disease |
| Q38857890 | Striated muscle function, regeneration, and repair |
| Q38535126 | The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy |
| Q55346713 | The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β. |
| Q89736397 | Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention in the treatment of Acute Myocardial Infarction |
| Q26860340 | Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement |
| Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. |
| Q49875736 | Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial Infarction. |
| Q38874087 | Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration |
Search more.